Camp Lejeune cancer lawsuit

Lawsuits against DuPont Chemours And 3M Accuse Them Of Contributing To Camp Lejeune Water Contamination

Firefighting foam is thought to have also contaminated the Camp Lejeune water supply causing cancer Parkinson's disease and other serious illnesses

Thursday, October 20, 2022 - It looks like private corporations may be held financially responsible for causing Camp Lejeune water cancer, not just the military. PFAS forever chemicals from firefighting foam have polluted the Camp Lejeune water supply and could be the cause of new types of cancer not listed as presumable from living, working, or being stationed at the Marine Corps Base. North Carolina Attorney General Josh Stein and the State of North Carolina have filed a failure to warn lawsuit against the makers of firefighting foam. According to Bloomberg, "The companies produced and sold aqueous film-forming foam (AFFF), which contains per- and polyfluoroalkyl substances (PFAS), Attorney General Josh Stein (D) said in two lawsuits filed on Tuesday in the state's Superior Court." Thousands of lawsuits are being filed accusing these companies of fraudulently selling firefighting foam to the military without warning them that firefighters and other servicemembers could develop cancer from coming into contact with the product. Lawsuits are also being filed by those who drank military base water contaminated with PFAS forever chemicals and subsequently developed cancer and other illnesses. Many types of Camp Lejeune cancer, including thyroid cancer and immune system suppression, are being attributed to drinking PFAS-contaminated tap water as are birth defects, miscarriages, and stillborn babies.

Lawsuits against DuPont, Chemours, and 3M are independent of suing the US Navy and Marine Corps unless the federal government is named as a co-defendant which could be the case. One aspect of lawsuits against public companies is that punitive damages may be sought in an amount ten times greater than the monetary awards that are available under the Camp Lejeune Justice Act. Every Camp Lejeune PFAS chemical lawsuit is taken individually, however, the DOJ action could set a precedent and cement the science underlying the cause of the diseases. The North Carolina lawsuit, along with one other, alleges that more than a dozen manufacturers of firefighting foam knew of the cancer risk the product presented to firefighters, and also of the potential of the chemical to contaminate groundwater leading to rivers, lakes, streams, and immediately into the tap water of those on Camp Lejeune. "In our filing with the court, we allege that these companies that made firefighting foam knew well how dangerous it was to our first responders and our natural resources," Stein said in a statement. "But they continued to sell this product to line their pockets at the expense of our health and our drinking water," according to Bloomberg. Tests of Camp Lejeune water have concluded that the level of toxic, carcinogenic, and life-threatening PFAS forever chemicals exceeds 25,000 parts per trillion (PPT), thousands of times more than the 0.004 parts per trillion (ppt) for PFOA and 0.02 ppt for PFOS deemed safe by EPA scientists. PFAS forever chemicals from firefighting foam have strong molecular bonds and do not degrade to the extent they can be eliminated by normal cellular functions, and accumulate in the body to levels presumed to cause cancer.

">

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.